New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
13:47 EDTAPKT, FIO, FTNT, ISIS, FBOptions with decreasing volume: APKT FIO FTNT ISIS FB
News For APKT;FIO;FTNT;ISIS;FB From The Last 14 Days
Check below for free stories on APKT;FIO;FTNT;ISIS;FB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 10, 2014
12:04 EDTFBFacebook testing tool that lets users schedule post deletions, The Next Web says
Facebook is testing a tool that will allow users to create self-destructing Facebook posts that disappear after a specified period of time, The Next Web reports. A spokesperson has confirmed, saying "We’re running a small pilot of a feature on Facebook for iOS that lets people schedule deletion of their posts in advance." Reference Link
September 9, 2014
14:32 EDTFBApple shows Facebook, Twitter apps on Apple Watch
09:36 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL KNDI NFLX YHOO TWTR TSLA C BAC FB MCD
07:17 EDTFBThe Wireless Association to hold a conference
Subscribe for More Information
September 8, 2014
14:00 EDTFBFacebook averages more than 1B video views per day, introducing video views
Subscribe for More Information
10:00 EDTFBFacebook may soon enter China, DoNews reports
Subscribe for More Information
09:40 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL TWTR TSLA YHOO BAC FB MSFT NFLX GILD MCD
06:34 EDTFBFacebook's Zuckerberg sees WhatsApp reaching up to 3B users, WSJ reports
Speaking at an event in Mexico City, Facebook CEO Mark Zuckerberg says messaging service WhatsApp could reach two to three billion users through a tie-up with Facebook, though WhatsApp will stay an independent service, the Wall Street Journal reports. Facebook agreed to pay $19B for WhatsApp earlier this year. Reference Link
September 7, 2014
14:24 EDTFBFacebook CEO ready to spend billions to spread internet access, Bloomberg says
Subscribe for More Information
September 5, 2014
11:51 EDTFBStocks with call strike movement; VALE FB
Subscribe for More Information
09:35 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GILD TSLA YHOO WFM SLW ABX GOOG FB BIDU
07:06 EDTFBFacebook rolls out three-step privacy check up to all users, WSJ reports
Subscribe for More Information
September 3, 2014
13:52 EDTFBSamsung collaborates with Oculus to introduce the Gear VR
Subscribe for More Information
10:40 EDTFTNTAnalyst sees security 'spending frenzy' amid high-profile hacks
Subscribe for More Information
09:36 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL TSLA TWTR PBR C GILD NFLX FB BIDU
06:44 EDTFTNTSecurity market demand 'rapidly' improving, says Piper Jaffray
Subscribe for More Information
September 2, 2014
19:28 EDTISISIsis Pharmaceutical licensing partner Antisense reports ATL1103 phase II results
Antisense Therapeutics, or ANP, reported the primary efficacy results from its phase II clinical trial of ATL1103 in patients with the potentially life threatening growth disorder, acromegaly. The phase II trial met its primary efficacy endpoint showing a statistically significant average reduction in the serum insulin-like growth factor-I, or sIGF-1, levels of 26% from baseline at week 14 at the 400mg per week dose tested. All patients treated with 400mg per week of ATL1103 had a reduction in sIGF-I levels from baseline at week 14. Greater reductions in sIGF-I were observed in patients who had lower body weights and thereby received a relatively higher dose per kg bodyweight with the patients who received 5.5 mg/kg per week showing a 36% average reduction in their sIGF-I levels. The positive results achieved in this Phase II trial position ATL1103 to move into Phase III stage of development. Consequently, ANP will accelerate out-licencing activities to secure a pharmaceutical development partner for the drug's further development. ANP has 4 products in its development pipeline that it has in-licensed from Isis Pharmaceuticals, including ATL1103.
09:41 EDTFBActive equity options trading on open
Subscribe for More Information
06:34 EDTFBEU sends questionnaire to rivals over Facebook-Whatsapp deal, WSJ says
European Union officials have sent a second wave of questions to competitors and customers of Facebook and Whatsapp, reports the Wall Street Journal. According to a questionnaire, EU officials are trying to understand what separates a social network from the messaging application and get to the heart of the competitive landscape. Reference Link
September 1, 2014
10:52 EDTFBEU regulators begin probe of Facebook deal with WhatsApp, WSJ says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use